Evaluations of Molecular Diagnostic Biomarkers


Assessment of Molecular Diagnostic Biomarkers A biomarker is a trademark that is even-handedly evaluated and surveyed as a pointer of common biologic methodology, pathogenic techniques, or pharmacologic responses to an accommodating mediation. It used to perceive or avow the proximity of an infirmity or condition of premium or to recognize individuals with a subtype of the ailment.



 


  • PCR enzyme-linked immunosorbent assay
  • Antibodies or proteins
  • Microbial assays
  • Analytical and clinical evaluations
  • Screening

Related Conference of Evaluations of Molecular Diagnostic Biomarkers

January 22-23, 2026

26th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
February 25-26, 2026

16th International Conference on Chemistry Meeting

Paris, France
February 26-27, 2026

29th World Congress on Materials Chemistry

Paris, France
June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Evaluations of Molecular Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in